<?xml version="1.0" encoding="UTF-8"?>
<Label drug="dopram" track="TAC2017_ADR">
  <Text>
    <Section name="adverse reactions" id="S1">    ADVERSE REACTIONS

  Adverse reactions reported coincident with the administration of DOPRAM (doxapram hydrochloride, USP) include:



   1. Central and Autonomic Nervous Systems

  Pyrexia, flushing, sweating; pruritus and paresthesia, such as a feeling of warmth, burning, or hot sensation, especially in the area of genitalia and perineum; apprehension, disorientation, pupillary dilatation, hallucinations, headache, dizziness, hyperactivity, involuntary movements, muscle spasticity, muscle fasciculations, increased deep tendon reflexes, clonus, bilateral Babinski, and convulsions.



   2. Respiratory

  Dyspnea, cough, hyperventilation, tachypnea, laryngospasm, bronchospasm, hiccough, and rebound hypoventilation.



   3. Cardiovascular

  Phlebitis, variations in heart rate, lowered T-waves, arrhythmias (including ventricular tachycardia and ventricular fibrillation), chest pain, tightness in chest. A mild to moderate increase in blood pressure is commonly noted and may be of concern in patients with severe cardiovascular diseases.



   4. Gastrointestinal

  Nausea, vomiting, diarrhea, desire to defecate.



   5. Genitourinary

  Stimulation of urinary bladder with spontaneous voiding; urinary retention. Elevation of BUN and albuminuria.



   6. Hemic and Lymphatic

  Hemolysis with rapid infusion. A decrease in hemoglobin, hematocrit, or red blood cell count has been observed in postoperative patients. In the presence of pre-existing leukopenia, a further decrease in WBC has been observed following anesthesia and treatment with doxapram hydrochloride.
</Section>
  </Text>
  <Mentions />
  <Relations />
  <Reactions />
</Label>
